Harke et al., Antithrombotic Strategies Targeting Thrombin Activities, Thrombin Receptor and Thrombin Generation, Thrombosis and Haemostasis, 1997, pp. 736-741. |
Kaiser, B., Thrombin and Factor Xa Inhibitors, Drugs of the Future, 1998, pp.423-436. |
Hara et al., DX-9065a, a New Synthetic, Potent Anticoagulant and Selective Inhibitor for Factor Xa, Thrombosis and Haemostasis, 1994, pp.314-319. |
Yamazaki et al., Effect of DX-9065a, an Orally Active, Newly Synthesized and Specific Inhibitor of Factor Xa, Against Experimental Disseminated Intravascular Coagulation in Rats, Thrombosis and Haemostasis, 1994, pp. 393-396. |
Kawasaki et al., Effect of a Synthetic Factor Xa Inhibitor, YM-60828, on Blood Vessel Patency in Combination with a Thrombolytic Agent and on Blood Loss from the Operation Site in a Rat Model or Arterial Thrombosis, Thrombosis and Haemostasis. |
Lefkovits, Jeffrey et al.: “Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model” J. Am. Coll. Cardiol. (1996), 28(7), 1858-1865. |